Nabriva Therapeutics plc

OTCPK:NBRV.F 주식 보고서

시가총액: US$646.0

Nabriva Therapeutics 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

H. Hogan

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기1.3yrs
CEO 소유권n/a
경영진 평균 재임 기간1.3yrs
이사회 평균 재임 기간6.8yrs

최근 관리 업데이트

Recent updates

Nabriva Therapeutics to effect 1-for-25 reverse stock split

Sep 15

Nabriva stock soars 19% on distribution deal with Er-Kim for bacterial pneumonia drug Xenleta

Jul 18

Need To Know: The Consensus Just Cut Its Nabriva Therapeutics plc (NASDAQ:NBRV) Estimates For 2022

Apr 04
Need To Know: The Consensus Just Cut Its Nabriva Therapeutics plc (NASDAQ:NBRV) Estimates For 2022

Bullish: Analysts Just Made A Noticeable Upgrade To Their Nabriva Therapeutics plc (NASDAQ:NBRV) Forecasts

Aug 11
Bullish: Analysts Just Made A Noticeable Upgrade To Their Nabriva Therapeutics plc (NASDAQ:NBRV) Forecasts

We Think Some Shareholders May Hesitate To Increase Nabriva Therapeutics plc's (NASDAQ:NBRV) CEO Compensation

Jul 22
We Think Some Shareholders May Hesitate To Increase Nabriva Therapeutics plc's (NASDAQ:NBRV) CEO Compensation

Nabriva Therapeutics plc 2021 Q1 - Results - Earnings Call Presentation

May 08

When Will Nabriva Therapeutics plc (NASDAQ:NBRV) Breakeven?

Feb 16
When Will Nabriva Therapeutics plc (NASDAQ:NBRV) Breakeven?

Nabriva Therapeutics announces proposed public offering

Dec 10

Nabriva Therapeutics shares gain as Sinovant expands Xenleta support in China

Dec 07

Nabriva Therapeutics plc 2020 Q3 - Results - Earnings Call Presentation

Nov 08

CEO

H. Hogan (61 yo)

1.3yrs

테뉴어

Mr. H. Michael Hogan III is Chief Executive Officer of Nabriva Therapeutics plc from July 6, 2023. He serves as Director of Metacrine, Inc. since March 23, 2023. He is Director of Otonomy, Inc. from Februa...


리더십 팀

이름위치테뉴어보상소유권
Colin Broom
Director7.1yrsUS$40.00k0.042%
$ 0.3
H. Hogan
Chief Executive Officer1.3yrs데이터 없음데이터 없음
David Maggio
Chief Financial Officer1.3yrs데이터 없음데이터 없음

1.3yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 관리: NBRV.F 의 관리팀은 경험 (평균 재직 기간 1.3 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Colin Broom
Director7.3yrsUS$40.00k0.042%
$ 0.3
Daniel Burgess
Independent Chairman of the Board7.3yrsUS$90.00k0.013%
$ 0.08
Mark H. Corrigan
Independent Director3.3yrsUS$50.00k0.0089%
$ 0.06
Stephen Webster
Independent Director7.3yrsUS$65.00k0.014%
$ 0.09
Steven Gelone
Director3.6yrsUS$579.23k0.041%
$ 0.3
Charles Rowland
Independent Director7.3yrsUS$55.00k0.019%
$ 0.1
Theodore Schroeder
Director6.2yrsUS$753.56k0.26%
$ 1.7
Lisa Dalton
Independent Director3.3yrsUS$47.50k0.011%
$ 0.07

6.8yrs

평균 재임 기간

64.5yo

평균 연령

경험이 풍부한 이사회: NBRV.F 의 이사회경험(평균 재직 기간 6.8 년)으로 간주됩니다.